Filter by Topic
Filter by Topic
Psychedelics and Mental Health Therapeutics
FDA Breakthrough Therapy Designation for LSD Formulation
MindMed Announces FDA Breakthrough Therapy Designation and Positive Findings from Phase 2B Study of LSD Formulation for Generalized Anxiety Disorder On March 7, 2024, the biopharmaceutical company Mind Medicine (MindMed)
Read article
News & Events
Phillips Lytle Launches Artificial Intelligence Practice Team
Multidisciplinary team of attorneys will assist clients across industries in navigating legal complexities of adopting and integrating AI into business operations Buffalo, N.Y. – Phillips Lytle LLP has announced the
Read more